Study maps hidden immune signals in type 1 diabetes

Type 1 diabetes researchers have made great progress in understanding the disease in the last two decades, even as a cure remains elusive. Now they have something that benefits any scientific effort. It's a map.

Stopping GLP-1 drugs can quickly erase cardiovascular benefits

Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S. adults now take these medications, which also provide cardiovascular ...

page 9 from 40